1. Fisher, RS, Acevedo, C, Arzimanoglou, A, et al ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55: 475–482.
Google Scholar | Crossref | Medline | ISI2. Hauser, WA, Beghi, E. First seizure definitions and worldwide incidence and mortality. Epilepsia 2008; 49: 8–12.
Google Scholar | Crossref | Medline | ISI3. Mattson, RH, Cramer, JA, Collins, JF, et al Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313: 145–151.
Google Scholar | Crossref | Medline | ISI4. Kwan, P, Brodie, MJ. Drug treatment of epilepsy: when does it fail and how to optimize its use. CNS Spectr 2004; 9: 110–119.
Google Scholar | Crossref | Medline5. French, JA, White, HS, Klitgaard, H, et al Development of new treatment approaches for epilepsy: unmet needs and opportunities. Epilepsia 2013; 54: 3–12.
Google Scholar | Crossref | Medline6. Wilcox, KS, Dixon-Salazar, T, Sills, GJ, et al Issues related to development of new antiseizure treatments. Epilepsia 2013; 54: 24–34.
Google Scholar | Crossref | Medline7. Perucca, E, Brodie, MJ, Kwan, P, et al 30 years of second-generation antiseizure medications: impact and future perspectives. Lancet Neurol 2020; 19: 544–556.
Google Scholar | Crossref | Medline8. French, JA, Kanner, AM, Bautista, J, et al Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62: 1252–1260.
Google Scholar | Crossref | Medline | ISI9. French, JA, Kanner, AM, Bautista, J, et al Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62: 1261–1273.
Google Scholar | Crossref | Medline | ISI10. Kanner, AM, Ashman, E, Gloss, D, et al Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2018; 91: 74–81.
Google Scholar | Crossref | Medline11. Kanner, AM, Ashman, E, Gloss, D, et al Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: treatment-resistant epilepsy: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2018; 91: 82–90.
Google Scholar | Medline12. Fisher, RS . An overview of the 2017 ILAE operational classification of seizure types. Epilepsy Behav 2017; 70: 271–273.
Google Scholar | Crossref | Medline13. Fisher, RS, Cross, JH, D’Souza, C, et al Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia 2017; 58: 531–542.
Google Scholar | Crossref | Medline14. Fisher, RS, Cross, JH, French, JA, et al Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 522–530.
Google Scholar | Crossref | Medline15. Scheffer, IE, Berkovic, S, Capovilla, G, et al ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 512–521.
Google Scholar | Crossref | Medline16. Proposal for revised clinical and electroencephalographic classification of epileptic seizures . From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981; 22: 489–501.
Google Scholar | Medline17. Proposal for revised classification of epilepsies and epileptic syndromes . Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30: 389–399.
Google Scholar | Medline18. Berg, AT, Berkovic, SF, Brodie, MJ, et al Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51: 676–685.
Google Scholar | Crossref | Medline | ISI19. Edlund, W, Gronseth, G, So, Y, et al Clinical practice guideline process manual. St Paul, MN: American Academy of Neurology, 2004, pp. 1–57.
Google Scholar20. Krumholz, A, Shinnar, S, French, J, et al Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2015; 85: 1526–1527.
Google Scholar | Crossref | Medline21. Glauser, T, Ben-Menachem, E, Bourgeois, B, et al ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006; 47: 1094–1120.
Google Scholar | Crossref | Medline | ISI22. Glauser, T, Ben-Menachem, E, Bourgeois, B, et al Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013; 54: 551–563.
Google Scholar | Crossref | Medline | ISI23. Appleton, RE, Freeman, A, Cross, JH. Diagnosis and management of the epilepsies in children: a summary of the partial update of the 2012 NICE epilepsy guideline. Arch Dis Child 2012; 97: 1073–1076.
Google Scholar | Crossref | Medline24. Nunes, VD, Sawyer, L, Neilson, J, et al Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance. BMJ 2012; 344: e281.
Google Scholar | Crossref | Medline25. Network, SIG . SIGN 143-Diagnosis and management of epilepsy in adults, 2018, https://www.sign.ac.uk/media/1079/sign143_2018.pdf
Google Scholar26. Network, SIG . Diagnosis and management of epilepsy in adults. SIGN national clinical guideline 143. Edinburgh: SIGN, 2015.
Google Scholar27. FDALabel , https://nctr-crs.fda.gov/fdalabel/ui/search (accessed 26 June 2021).
Google Scholar28. Fiest, KM, Sauro, KM, Wiebe, S, et al Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology 2017; 88: 296–303.
Google Scholar | Crossref | Medline29. Pitkanen, A . Therapeutic approaches to epileptogenesis—hope on the horizon. Epilepsia 2010; 51: 2–17.
Google Scholar | Crossref | Medline30. Kwan, P, Brodie, MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314–319.
Google Scholar | Crossref | Medline | ISI31. Marson, A, Jacoby, A, Johnson, A, et al Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005; 365: 2007–2013.
Google Scholar | Crossref | Medline | ISI32. Kwan, P, Arzimanoglou, A, Berg, AT, et al Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069–1077.
Google Scholar | Crossref | Medline | ISI33. Semah, F, Picot, MC, Adam, C, et al Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998; 51: 1256–1262.
Google Scholar | Crossref | Medline | ISI34. Stephen, LJ, Brodie, MJ. Pharmacotherapy of epilepsy: newly approved and developmental agents. CNS Drugs 2011; 25: 89–107.
Google Scholar | Crossref | Medline | ISI35. Marson, AG, Kadir, ZA, Hutton, JL, et al The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997; 38: 859–880.
Google Scholar | Crossref | Medline | ISI36. Vajda, FJ . Pharmacotherapy of epilepsy: new armamentarium, new issues. J Clin Neurosci 2007; 14: 813–823.
Google Scholar | Crossref | Medline37. Epilepsy Foundation . Epilepsy pipeline tracker, https://www.epilepsy.com/pipeline-listing-page (accessed 25 April 2021).
Google Scholar38. Sills, GJ, Rogawski, MA. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology 2020; 168: 107966.
Google Scholar | Crossref | Medline39. Devinsky, O, Vezzani, A, O’Brien, TJ, et al Epilepsy. Nat Rev Dis Primers 2018; 4: 18024.
Google Scholar | Crossref | Medline40. Karceski, S, Morrell, M, Carpenter, D. The expert consensus guideline series treatment of epilepsy. Epilepsy Behav 2001; 2: A1–A50.
Google Scholar | Crossref | Medline | ISI41. Marson, AG, Al-Kharusi, AM, Alwaidh, M, et al The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1000–1015.
Google Scholar | Crossref | Medline | ISI42. Marson, AG, Al-Kharusi, AM, Alwaidh, M, et al The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1016–1026.
Google Scholar | Crossref | Medline | ISI43. Marson, A, Burnside, G, Appleton, R, et al The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021; 397: 1375–1386.
Google Scholar | Crossref | Medline44. Richens, A, Davidson, DL, Cartlidge, NE, et al A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. J Neurol Neurosurg Psychiatry 1994; 57: 682–687.
Google Scholar | Crossref | Medline | ISI45. Verity, CM, Hosking, G, Easter, DJ. A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group. Dev Med Child Neurol 1995; 37: 97–108.
Google Scholar | Crossref | Medline46. de Silva, M, MacArdle, B, McGowan, M, et al Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996; 347: 709–713.
Google Scholar | Crossref | Medline47. Heller, AJ, Chesterman, P, Elwes, RD, et al Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry 1995; 58: 44–50.
Google Scholar | Crossref | Medline48. Mattson, RH, Cramer, JA, Collins, JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 1992; 327: 765–771.